134 related articles for article (PubMed ID: 19959309)
1. Evaluation of glycopeptide use in nine French hospitals.
Alfandari S; Levent T; Descamps D; Hendricx S; Bonenfant C; Taines V; Cattoen C; Arimane O; Grandbastien B
Med Mal Infect; 2010 Apr; 40(4):232-7. PubMed ID: 19959309
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of glycopeptide prescription and therapeutic drug monitoring at a university hospital.
Roustit M; François P; Sellier E; Roch N; Vittoz JP; Foroni L; Stahl JP; Pavese P
Scand J Infect Dis; 2010 Mar; 42(3):177-84. PubMed ID: 20001224
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
[TBL] [Abstract][Full Text] [Related]
4. [Prospective assessment of glycopeptides prescriptions in a general hospital].
Levent T; Lambiotte F; Vasseur M; De Zorzi S; Gosteau L; Paradis P
Med Mal Infect; 2005; 35(7-8):411-6. PubMed ID: 16139457
[TBL] [Abstract][Full Text] [Related]
5. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines. Hospital Infection Control Practice Advisory Committee.
Salemi C; Becker L; Morrissey R; Warmington J
Clin Perform Qual Health Care; 1998; 6(1):12-6. PubMed ID: 10177043
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
[TBL] [Abstract][Full Text] [Related]
7. A retrospective drug utilization evaluation of vancomycin usage in paediatric patients.
Hing WC; Bek SJ; Lin RT; Li SC
J Clin Pharm Ther; 2004 Aug; 29(4):359-65. PubMed ID: 15271103
[TBL] [Abstract][Full Text] [Related]
8. Appropriateness of glycopeptide use in a hospital in Italy.
Bianco A; Rizza P; Scaramuzza G; Pavia M
Int J Antimicrob Agents; 2006 Feb; 27(2):113-9. PubMed ID: 16417993
[TBL] [Abstract][Full Text] [Related]
9. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
[TBL] [Abstract][Full Text] [Related]
10. [Dosage adjustment of vancomycin in continuous infusion in critically ill-patients].
Carricajo A; Forgeot A; Morel J; Auboyer C; Zeni F; Aubert G
Ann Fr Anesth Reanim; 2010 Jan; 29(1):55-7. PubMed ID: 20074899
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
Kitzis MD; Goldstein FW
Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin use in 2 Ontario tertiary care hospitals: a survey.
Kwan T; Lin F; Ngai B; Loeb M
Clin Invest Med; 1999 Dec; 22(6):256-64. PubMed ID: 10664867
[TBL] [Abstract][Full Text] [Related]
14. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
[TBL] [Abstract][Full Text] [Related]
15. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis].
Jourdan C; Convert J; Peloux A; Boussaid O; Grando J; Tigaud S
Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482
[TBL] [Abstract][Full Text] [Related]
16. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
Pea F; Brollo L; Viale P; Pavan F; Furlanut M
J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring of vancomycin in pediatrics].
Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
[TBL] [Abstract][Full Text] [Related]
18. Use of albumin in three French university hospitals: is prescription monitoring still useful in 2004?
Pradel V; Tardieu S; Micallef J; Signoret A; Villano P; Gauthier L; Vanelle P; Blin O;
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):79-85. PubMed ID: 17006960
[TBL] [Abstract][Full Text] [Related]
19. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
20. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
Wang JT; Liao HI; Wu Lin FL; Chang SC
Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
